Experience of cerebrolizate use for treatment of neurologic patients

Abstract

The data on dynamic examination of cerebrolizate effect in 106 patients with craniocerebral trauma impacts, syringomielia and vascular brain diseases are given. It is apparent that the use of cerebrolizate improves and quickens the treatment of neurologic patients. Therapeutic efficiency of the drug was expressed in improvement of general state of the patient, diminution of evidence of neurologic deficiency, corrective influence on physico chemical characteristics of blood, metabolic processes, bioelectrical activity of the brain and hemodynamic in dices.